These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29569771)

  • 1. Identification of the acid-induced degradation products of omeprazole and 5-hydroxyomeprazole by high-resolution mass spectrometry.
    Roberts J; McNaughtan ML; MacLachlan J; Hunter C; Pahl O
    Rapid Commun Mass Spectrom; 2018 Jun; 32(12):929-941. PubMed ID: 29569771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the presence of omeprazole in waters by liquid chromatography coupled to low and high resolution mass spectrometry: degradation experiments.
    Boix C; Ibáñez M; Sancho JV; Niessen WM; Hernández F
    J Mass Spectrom; 2013 Oct; 48(10):1091-100. PubMed ID: 24130012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversed-phase high performance liquid chromatographic method for the determination of lansoprazole, omeprazole and pantoprazole sodium sesquihydrate in presence of their Acid-induced degradation products.
    El-Sherif ZA; Mohamed AO; El-Bardicy MG; El-Tarras MF
    Chem Pharm Bull (Tokyo); 2006 Jun; 54(6):814-8. PubMed ID: 16755049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of new omeprazole metabolites in wastewaters and surface waters.
    Boix C; Ibáñez M; Zamora T; Sancho JV; Niessen WM; Hernández F
    Sci Total Environ; 2014 Jan; 468-469():706-14. PubMed ID: 24061062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantiomeric separation of omeprazole and its metabolite 5-hydroxyomeprazole using non-aqueous capillary electrophoresis.
    Olsson J; Stegander F; Marlin N; Wan H; Blomberg LG
    J Chromatogr A; 2006 Oct; 1129(2):291-5. PubMed ID: 16854427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow, spontaneous degradation of lansoprazole, omeprazole and pantoprazole tablets: isolation and structural characterization of the toxic antioxidants 3H-benzimidazole-2-thiones.
    Rajab A; Touma M; Rudler H; Afonso C; Seuleiman M
    Pharmazie; 2013 Sep; 68(9):749-54. PubMed ID: 24147343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of omeprazole and 5'-hydroxyomeprazole in human plasma by liquid chromatography-tandem mass spectrometry.
    Woolf EJ; Matuszewski BK
    J Chromatogr A; 1998 Dec; 828(1-2):229-38. PubMed ID: 9916309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of two main urinary metabolites of [14C]omeprazole in humans.
    Renberg L; Simonsson R; Hoffmann KJ
    Drug Metab Dispos; 1989; 17(1):69-76. PubMed ID: 2566473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High resolution mass spectrometry to investigate omeprazole and venlafaxine metabolites in wastewater.
    Boix C; Ibáñez M; Bagnati R; Zuccato E; Sancho JV; Hernández F; Castiglioni S
    J Hazard Mater; 2016 Jan; 302():332-340. PubMed ID: 26476321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantioselective quantification of omeprazole and its main metabolites in human serum by chiral HPLC-atmospheric pressure photoionization tandem mass spectrometry.
    Martens-Lobenhoffer J; Reiche I; Tröger U; Mönkemüller K; Malfertheiner P; Bode-Böger SM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 857(2):301-7. PubMed ID: 17702674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation recruited from an Oriental population.
    Sohn DR; Kobayashi K; Chiba K; Lee KH; Shin SG; Ishizaki T
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1195-202. PubMed ID: 1527724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of lansoprazole and omeprazole in the aquatic environment.
    DellaGreca M; Iesce MR; Previtera L; Rubino M; Temussi F; Brigante M
    Chemosphere; 2006 May; 63(7):1087-93. PubMed ID: 16289231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid decomposition of omeprazole in the absence of thiol: a differential pulse polarographic study at the static mercury drop electrode (SMDE).
    Qaisi AM; Tutunji MF; Tutunji LF
    J Pharm Sci; 2006 Feb; 95(2):384-91. PubMed ID: 16380990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the quantitative performance of a Q-Exactive high-resolution mass spectrometer with that of a triple quadrupole tandem mass spectrometer for the analysis of illicit drugs in wastewater.
    Fedorova G; Randak T; Lindberg RH; Grabic R
    Rapid Commun Mass Spectrom; 2013 Aug; 27(15):1751-62. PubMed ID: 23821568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism.
    Andersson T; Miners JO; Veronese ME; Tassaneeyakul W; Tassaneeyakul W; Meyer UA; Birkett DJ
    Br J Clin Pharmacol; 1993 Dec; 36(6):521-30. PubMed ID: 12959268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability-indicating methods for determining omeprazole and octylonium bromide in the presence of their degradation products.
    el-Kousy NM; Bebawy LI
    J AOAC Int; 1999; 82(3):599-606. PubMed ID: 10367377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice.
    Tassaneeyakul W; Vannaprasaht S; Yamazoe Y
    Br J Clin Pharmacol; 2000 Feb; 49(2):139-44. PubMed ID: 10671908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of omeprazole, hydroxyomeprazole and omeprazole sulfone using automated solid phase extraction and micellar electrokinetic capillary chromatography.
    Pérez-Ruiz T; Martínez-Lozano C; Sanz A; Bravo E; Galera R
    J Pharm Biomed Anal; 2006 Sep; 42(1):100-6. PubMed ID: 16280228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of omeprazole and its metabolites in human plasma by liquid chromatography-mass spectrometry.
    Kanazawa H; Okada A; Matsushima Y; Yokota H; Okubo S; Mashige F; Nakahara K
    J Chromatogr A; 2002 Mar; 949(1-2):1-9. PubMed ID: 11999727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrophotometric and chromatographic determination of omeprazole in pharmaceutical formulations.
    Gallardo V; López-Viota M; Sierra J; Ruiz MA
    Pharm Dev Technol; 2009; 14(5):516-23. PubMed ID: 19267285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.